Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model

...erapies MARKHAM, Ontario, Nov. 6 /PRNewswire/ -- cytochroma today announced positive comparative data on a nov...ns in serum calcium or phosphorus were observed. cytochroma has granted Mitsubishi Tanabe Pharma Corporation (...ts and patent applications exclusively licensed to cytochroma from the Johns Hopkins University. About Chronic...

Cytochroma in Medical Technology

Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection

... MARKHAM, ON, June 28, 2007 /PRNewswire/ - cytochroma Inc. announced today positive data from a Phase I ...ts and patent applications exclusively licensed to cytochroma Inc. from the Johns Hopkins University. About Ch...dening North American epidemic of obesity. About cytochroma Inc. ...

Cytochroma in Biological Technology

Cytochroma announces appointment of Ulrik Spork to Board of Directors

... MARKHAM, ON, Oct. 30 /PRNewswire/ - cytochroma today announced the appointment of Ulrik Spork to ...lso like to thank Soren Schifter for his advice to cytochroma over the years, and wish him well in the future." ...c in International Economics. About Cytochroma cytochroma is a clinical stage specialty pharmaceutical compa...

Cytochroma appoints Steven I. Engel as Vice President of Regulatory Affairs and Quality Assurance

... MARKHAM, ON, Sept. 16 /PRNewswire/ - cytochroma today announced that it has appointed Steven I. En...ate a leading specialty pharmaceutical company." cytochroma has a diverse portfolio of vitamin D-based therape...t of vitamin D insufficiency. About Cytochroma cytochroma is a clinical stage specialty pharmaceutical compa...

Cytochroma and Mitsubishi Tanabe form partnership for chronic kidney disease therapies in U.S. and Asia

...KHAM, ON, and OSAKA, Japan, July 30 /PRNewswire/ - cytochroma and Mitsubishi Tanabe Pharma Corporation ("MTPC") ...panies have signed a license agreement under which cytochroma granted MTPC an exclusive license in the U.S. and ...compounds to CTA018 for the same territories, with cytochroma retaining all rights to CTA018 and these follow-on...

Cytochroma Closes $45 Million Series C Financing

...g Candidates MARKHAM, ON, July 30 /PRNewswire/ - cytochroma today announced the closing of a CDN $45 million S...armaceutical company. This latest funding provides cytochroma with the financial capability to aggressively driv...ank Elizabeth for her guidance in helping to bring cytochroma to this important point in its development. I am a...

Cytochroma Appoints R. Richard Wieland II As CFO

... MARKHAM, ON, May 12 /PRNewswire/ - cytochroma today announced that it has appointed R. Richard W...inancial Officer (CFO). Mr. Wieland, 63, brings to cytochroma nearly 40 years of experience in finance and finan...d sustainable specialty pharmaceutical company." cytochroma has a diverse portfolio of Vitamin D-based therape...

Cytochroma opens U.S. headquarters in Illinois

... MARKHAM, ON, April 29 /PRNewswire/ - cytochroma today announced the opening of its U.S. headquarte...ent and CEO, commented, "This is an ideal time for cytochroma to establish U.S. operations, as we move our lead ...ong intellectual capital present in the region." cytochroma has a diverse portfolio of Vitamin D-based therape...

Cytochroma initiates Phase I/II clinical trial of CTAP101 Capsules for vitamin D insufficiency in chronic kidney disease

... MARKHAM, ON, Nov. 20 /PRNewswire/ - cytochroma Inc. announced today that it has commenced dosing ...ts including dialysis or kidney transplant. About cytochroma Inc. cytochroma (http://www.cytochroma.com ) is a specialty pharm...

Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO

...ted this year as the company pursues additional venture capital among its 10 existing Canadian investment groups and new American investors. Thus far, cytochroma has raised $39 million in private capital from its Canadian sources, and already has commitments from them as part of its attempt to raise an addition...

Genzyme sues former Bone Care employees

..." Quinn stated. "We're asking the court to prevent cytochroma from using Bone Care's inventions." The issue m...ocess. Whether these ideas belong to Genzyme or cytochroma might be up to the court to decide. Fishing ex...an gain patent protection. The lawsuit comes as cytochroma is working to develop a $30 million round of ventu...

Madison life-science firms agree to co-develop kidney product

...hosphorus levels within normal limits. Under the terms of the agreement, cytochroma will gain exclusive rights to develop and commercialize aOvaTech's propriet...s on the sale of products covered by the license. aOvaTech also will supply cytochroma with material for development and commercialization. Keith Crawford, vi...